https://www.selleckchem.com/pr....oducts/BafilomycinA1
Background Comorbidities are associated with higher health care costs, complex management, and poorer health outcomes. Identification and treatment of comorbid conditions in pediatric alopecia areata (AA) patients could provide an opportunity to improve health outcomes. Objectives To determine the prevalence of comorbidities among pediatric patients with AA using a large de-identified aggregated patient database. Methods This is a cross-sectional study using aggregated health record data through April 1, 2019. Patients ≤18 years o
Like
Comment
Share
